Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.

Por: Jacobs, S, Robidoux, A, Abraham, J, Perez-Garcia, J, La Verde, N, Orcutt, J, Cazzaniga, M, Piette, F, Antolin, S, Aguirre, E, Cortes, J, Llombart-Cussac, A, Di Cosimo, S, Kim, R, Feng, H, Lipchik, C, Lucas, P, Srinivasan, A, Wang, Y, Song, N, Gavin, P, Balousek, A, Paik, S, Allegra, C, Wolmark, N and Pogue-Geile, K

---

Publicada: 22 ene 2020 Ahead of Print: 22 ene 2020

---

---

Filiaciones:
Jacobs, S:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Robidoux, A:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Ctr Hosp Univ Montreal, Montreal, PQ, Canada

Abraham, J:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Cleveland Clin, Cleveland, OH 44106 USA

Perez-Garcia, J:
 IOB Inst Oncol, Quironsalud Grp, Madrid, Spain

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

La Verde, N:
 ASST Fatebenefratelli Sacco Luigi Sacco, Milan, Italy

 ASST Fatebenefratelli Sacco Fatebenefratelli, Milan, Italy

Orcutt, J:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Roper St Francis Healthcare, Charleston, SC USA

Cazzaniga, M:
 Med Scientia Innovat Res MedSIR, Barcelona, Spain

 Azienda Osped San Gerardo, Monza, Italy

Piette, F:
 IDDI, Louvain La Neuve, Belgium

Antolin, S:
 Hosp Univ, Coruna, Spain

Aguirre, E:
 Med Scientia Innovat Res MedSIR, Barcelona, Spain

Cortes, J:
 IOB Inst Oncol, Quironsalud Grp, Madrid, Spain

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

:
 Med Scientia Innovat Res MedSIR, Barcelona, Spain

Di Cosimo, S:
 Med Scientia Innovat Res MedSIR, Barcelona, Spain

 Fdn IRCCS Ist Nazl Tumori, Milan, Italy

Kim, R:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Feng, H:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Lipchik, C:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Lucas, P:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA

Srinivasan, A:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Wang, Y:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Song, N:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Gavin, P:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Balousek, A:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

Paik, S:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea

 Yonsei Univ, Coll Med, Dept Med Oncol, Seoul, South Korea

Allegra, C:
 Univ Florida Hlth, Dept Med, Gainesville, FL USA

Wolmark, N:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA

 Univ Pittsburgh, Pittsburgh, PA 15212 USA

Pogue-Geile, K:
 NSABP Fdn Inc, Nova Tower 2,Two Allegheny Ctr Ste 1200, Pittsburgh, PA 15212 USA